We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

VST:NYSEVistra Corp. analysis

Data as of Jun 18, 2026 - not real-time

Latest price
$163.43
Risk: medium
7/10Medium risk

Summary

Vistra Corp. (VST) is trading at $163.43, roughly 10% below its 20‑day SMA ($154.00) and just under the 50‑day SMA ($154.15), indicating short‑term price weakness despite a bullish MACD histogram (+1.44) and an RSI of 60, which suggests lingering upside momentum. The company boasts a 43% YoY revenue growth rate, a solid operating margin of 26.6%, and a forward EPS of $10.99, driving a forward P/E of ~15 versus a trailing P/E of 27.3, well above the industry average of 20.5.
Recent material news highlights Vistra’s selection as the preferred power provider for a $10 billion KKR‑backed AI infrastructure venture, underscoring growing demand from data centers and hyperscalers, while analysts cite strong cash flow and long‑term PPAs as catalysts. However, the stock faces high volatility (51% 30‑day) and a beta of 1.59, coupled with a massive debt‑to‑equity ratio (>350), which tempers the upside potential despite a 36% upside/downside estimate.

Market outlook

Short term

< 1 year

Neutral

Model confidence6/106 out of 10

Key factors

  • Bearish trend direction despite bullish MACD
  • High short‑term volatility and elevated beta
  • Price near support level with limited upside in next weeks

Medium term

1–3 years

Positive

Model confidence8/108 out of 10

Key factors

  • Strong revenue growth and operating margins
  • Forward P/E compression to ~15 indicating value upside
  • AI‑driven power demand from KKR‑backed infrastructure partnership

Long term

> 3 years

Positive

Model confidence9/109 out of 10

Key factors

  • Diversified generation mix with nuclear and renewable assets
  • Long‑term PPAs with hyperscalers securing stable cash flow
  • Upside potential of ~36% versus downside risk, supported by analyst strong‑buy consensus

Key metrics

Financial health

Revenue Growth43.40%
Profit Margin11.53%
P/E Ratio27.3
ROE42.90%
ROA6.02%
Debt/Equity355.19
P/B Ratio21.1
Op. Cash Flow$4.7B
Free Cash Flow$476.9M
Industry P/E20.5

Technical analysis

TrendBearish
RSI60.5
Support$137.91
Resistance$170.32
MA 20$154.00
MA 50$154.15
MA 200$170.27
MACDBullish
VolumeStable
Fear & Greed Index91.32

Valuation

Target Price$223.00
Upside/Downside36.45%
GradeFair
TypeBlend

Risk assessment

Beta1.59
Volatility51.43%
Sector RiskMedium
Reg. RiskHigh
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.